These compounds may interact with:
Substance-P receptor
Potentially involved in: carcinoma; pain agnosia; asthma; retinitis pigmentosa; migraine; inflammatory bowel disease; irritable bowel syndrome; cystitis; pancreatitis; complex regional pain syndrome; cancer; motion sickness; telogen effluvium; attention deficit hyperactivity disorder; pain disorder; epicondylitis; alcoholic intoxication, chronic; bipolar disorder; bronchial diseases; mental depression
Disease data sourced from Pharos.